Strains inducing higher levels of the anti-inflammatory cytokine IL-10 and lower levels of the pro-Th1 cytokines IL-12 and IFNγ after in vitro stimulation of human peripheral mononuclear cells (PBMC), offered the best protection in the in vivo colitis model used. The gene discussed is IL10; the disease is colitis.